https://ginabattaglia.journoportfolio.comRSS Feed for Gina Battaglia Medical WritingenMon, 03 Aug 2026 00:00:00 +0100https://diagnostics.roche.com/global/en/diagnostics-insights/hiv-aids-tests-for-early-infant-diagnosis-in-south-africa.htmlThe Global Access Program is the Roche Group’s proactive response to an enormous humanitarian challenge. Since its inception in 2014, the program has increased access to HIV testing at substantially reduced prices in sub-Saharan Africa and countries where the disease burden is highest. The Global Access Program focuses on the complete continuum of care, from testing to monitoring, education, and works to optimise efforts on a regional basis. One of the reasons why we started the Global Access Pr...Mon, 03 Aug 2026 00:00:00 +0100https://diagnostics.roche.com/global/en/diagnostics-insights/hiv-aids-tests-for-early-infant-diagnosis-in-south-africa.htmlhttps://media.journoportfolio.com/users/513979/uploads/f69103fe-0850-40e5-bc20-05842ebecbf7.pdfMon, 03 Aug 2026 00:00:00 +0100https://media.journoportfolio.com/users/513979/uploads/f69103fe-0850-40e5-bc20-05842ebecbf7.pdfhttps://media.journoportfolio.com/users/513979/uploads/5baa8d24-a99b-4a1e-aacc-12aadba339a9.pdfMon, 03 Aug 2026 00:00:00 +0100https://media.journoportfolio.com/users/513979/uploads/5baa8d24-a99b-4a1e-aacc-12aadba339a9.pdfhttps://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70304Management of prostate cancer (PC) has evolved rapidly with the development of treatment combinations based on presumed risk for disease progression, but gaps remain in this risk-based treatment approach. The “Bridging the Gaps (BTG) in Prostate Cancer” meeting was held on March 27, 2025, in Weehawken, New Jersey and included a diverse group of PC experts who practice in academic, community, and veterans health care system settings in medical oncology, urology, and radiation oncology. These pane...Mon, 03 Aug 2026 00:00:00 +0100https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70304https://media.journoportfolio.com/users/513979/uploads/47f7b461-1a78-4a56-8a1a-b7bc0be98b31.pdfMon, 03 Aug 2026 00:00:00 +0100https://media.journoportfolio.com/users/513979/uploads/47f7b461-1a78-4a56-8a1a-b7bc0be98b31.pdfhttps://pmc.ncbi.nlm.nih.gov/articles/PMC4420167/pdf/icns_12_3-4_27.pdfWed, 22 Jul 2026 00:00:00 +0100https://pmc.ncbi.nlm.nih.gov/articles/PMC4420167/pdf/icns_12_3-4_27.pdfhttps://www.visionlearning.com/en/library/Chemistry/1/Diffusion-I/216/If you’ve ever made cookies and left the kitchen door open, you’re probably aware that the aroma spreads throughout the house. It is strongest in the kitchen, where the cookies are baking, a little less in the dining or living room, and least in the upstairs corner bedroom. And if the door is closed in the corner bedroom, the cookie scent is even weaker. This is a delicious example of diffusion, or the movement of matter from a region of high concentration (the cookie pan in the kitchen) to a...Mon, 20 Jul 2026 00:00:00 +0100https://www.visionlearning.com/en/library/Chemistry/1/Diffusion-I/216/https://www.patientcareonline.com/view/a-look-at-lynkuet-elinzanetant-for-the-treatment-of-moderate-to-severe-vasomotor-symptomsElinzanetant is a novel, dual neurokinin (NK) 1,3 receptor agonist that has recently been approved for the treatment of moderate to severe vasomotor symptoms (VMS), commonly known as hot flashes, associated with menopause.1 VMS are extremely common during menopause, affecting up to 80% of women (of these, approximately one-third have highly frequent or severe symptoms), and often persist for 7 to 10 years after the last menstrual period.2,3 VMS can contribute to sleep disturbances (reported in u...Wed, 05 Nov 2025 00:00:00 +0000https://www.patientcareonline.com/view/a-look-at-lynkuet-elinzanetant-for-the-treatment-of-moderate-to-severe-vasomotor-symptomshttps://www.onclive.com/view/emerging-uses-for-circulating-tumor-cell-technologyDetection of circulating tumor cells (CTCs), which are released from primary or metastatic lesions into the bloodstream and are the “seeds” for distant metastatic lesions, has been of interest in cancer research and treatment because these cells can potentially provide information on cancer detection, prognosis, and likelihood of treatment response with minimally invasive methods (eg, a blood draw).1 Development of validated technologies to isolate and detect CTCs has been slow because of their...Mon, 21 Aug 2023 00:00:00 +0100https://www.onclive.com/view/emerging-uses-for-circulating-tumor-cell-technologyhttps://www.curetoday.com/view/contagious-enthusiasmAn individual with cancer faces plenty of challenges, so when a viral infection sets up camp in the body, it’s never welcome news — that is, unless the virus has been modified and introduced intentionally to kill cancer.That’s the concept behind oncolytic virus therapies, which are generating attention from researchers and pharmaceutical developers for their potential to create a new class of immuneenhancing drugs.U.S. clinical trials are exploring more than 16 genetically modified virus therapi...Wed, 20 Jun 2018 00:00:00 +0100https://www.curetoday.com/view/contagious-enthusiasmhttps://www.bioradiations.com/assessing-cell-health-necroptosis/Necroptosis is a programmed form of necrotic cell death that is dependent on activation of receptor interacting protein kinase-3 (RIPK3) and occurs when caspase activation is insufficient or blocked. Unlike necrosis, an unregulated form of cell death caused by external physicochemical stress, necroptosis is highly regulated and acts as a defense mechanism or escape route for cells infected with viruses that inhibit apoptosis signaling proteins (examples of these viruses include the murine cytome...Wed, 15 Mar 2017 00:00:00 +0000https://www.bioradiations.com/assessing-cell-health-necroptosis/https://www.onclive.com/view/alaskan-oncology-practices-operate-by-remoteEugene Huang, MD Obtaining quality cancer care in Alaska is often difficult and expensive owing to the sparse highway network and the scattered nature of the state’s population of 736,000 people, who are spread out over more than a half-million square miles. For oncology practices, the use of local primary care providers to aid oncologists and recent advances in telemedicine have helped to overcome these barriers and increase the availability of cost-effective, evidence-based medicine.For radiati...Thu, 03 Mar 2016 00:00:00 +0000https://www.onclive.com/view/alaskan-oncology-practices-operate-by-remotehttps://www.bioradiations.com/in-pursuit-of-ig-nobility-the-ig-nobel-prize/Believe it or not, these are internationally acclaimed, award-winning research topics in physics, medicine, and chemistry. They did not quite meet the criteria for the Nobel Prize, but were honored at the 25th First Annual Ig Nobel Prize ceremony on September 17, 2015. Led by Marc Abrahams, editor and cofounder of the magazine Annals of Improbable Research, the ceremony honors “achievements that make people laugh, then think — in that order,” according to the Improbable Research website.The Ig N...Tue, 10 Nov 2015 00:00:00 +0000https://www.bioradiations.com/in-pursuit-of-ig-nobility-the-ig-nobel-prize/https://www.bioradiations.com/melting-body-fat-is-it-in-your-head/Muscles may not be the only organ that burns body fat. A recent study published in Cell showed that directly stimulating neurons in adipose (fat) tissue may induce breakdown, providing insight on novel therapies to combat obesity. Scientists first identified leptin, a hormone produced by fat cells that acts as an “adipostat”, 20 years ago. Low fat stores tend to correspond with low levels of the hormone, which increases appetite and lowers basal metabolism. High fat stores are often associated...Tue, 13 Oct 2015 00:00:00 +0100https://www.bioradiations.com/melting-body-fat-is-it-in-your-head/https://www.bioradiations.com/researcher-profile-suzanne-topalian-pioneers-pd-1-inhibitor-drug-to-treat-advanced-cancer/After 29 years of research in cancer immunotherapy, Dr. Suzanne Topalian has been acknowledged as one of “Ten People Who Mattered This Year” in the December 2014 issue of Nature for her pioneering research on programmed cell death protein-1 (PD-1) inhibitors. The road to this prestigious accomplishment began with a two-year fellowship at the NIH National Cancer Institute in Bethesda, MD under cancer immunologist Dr. Steven Rosenberg, who was credited as the first modern researcher to use immuno...Wed, 27 May 2015 00:00:00 +0100https://www.bioradiations.com/researcher-profile-suzanne-topalian-pioneers-pd-1-inhibitor-drug-to-treat-advanced-cancer/https://www.bioradiations.com/ebola-new-techniques-for-diagnosis-treatment-and-prevention/Within one year, Ebola virus disease (EVD) has gone from relative anonymity to a worldwide source of fear. This disease has been brought to the forefront of the public’s attention due to its gruesome symptoms (which include vomiting, diarrhea, and hemorrhagic bleeding), high mortality rate (up to 90% according to some reports), and lack of specific treatment options. On March 23, 2014, the World Health Organization (WHO) was first notified of an outbreak in Guinea, and the virus has since then s...Tue, 09 Dec 2014 00:00:00 +0000https://www.bioradiations.com/ebola-new-techniques-for-diagnosis-treatment-and-prevention/